WallStreetZenWallStreetZen

NASDAQ: INBX
Inhibrx Biosciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Inhibrx Biosciences revenue was $1.30M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INBX annual revenue was $1.3M, with 550% growth year-over-year.

INBX past revenue growth

How has INBX's revenue growth performed historically?

Company
550%
Industry
505.02%
Market
37.01%
INBX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INBX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INBX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INBX revenue history

Current Revenue
$1.3M
Current Earnings
-$140.1M
Current Profit Margin
-10,773.5%

Be the first to know when INBX announces revenue.

INBX Revenue History By Year

INBX Yearly RevenueINBX RevenueINBX ChangeINBX Revenue Growth
2025-12-31$1.30M$1.10M+550.00%
2024-12-31$200.00k-$1.60M-88.89%
2023-12-31$1.80M-$392.00k-17.88%
2022-12-31$2.19MN/AN/A

1 of 1

Inhibrx Biosciences Revenue FAQ

What was INBX's revenue last quarter?

On Invalid Date, Inhibrx Biosciences (NASDAQ: INBX) reported Q4 2025 revenue of $0.00 up 100% year over year. In the same quarter last year, Inhibrx Biosciences's revenue was $100.00 thousand.

What was Inhibrx Biosciences's revenue in 2025?

Inhibrx Biosciences's annual revenue for the twelve months ending Dec 31, 2025 was $1.30 million, a 550% increase year over year.

How much does Inhibrx Biosciences make in a day?

Based on Inhibrx Biosciences annual revenue for the past three years, INBX makes an average of $3,013.70 per day.

What was Inhibrx Biosciences's annual revenue growth in the past year?

As of Q2 2026, Inhibrx Biosciences's revenue has grown 550% year over year. This is 44.98 percentage points higher than the US Biotechnology industry revenue growth rate of 505.02%. Inhibrx Biosciences's revenue in the past year totaled $1.30 million.

How much does Inhibrx Biosciences make in a year?

Inhibrx Biosciences's revenue by year for the past three years is:
  • Inhibrx Biosciences's revenue for the twelve months ending Dec 31, 2025 was $1.30 million, a 550% increase year over year.
  • Inhibrx Biosciences's annual revenue for Dec 31, 2024 was $200.00 thousand, a 88.89% decrease from 2023.
  • Inhibrx Biosciences's annual revenue for 2023 was $1.80 million, a 17.88% decrease from 2022.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.